Eddy Sayeed

Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

Frances Priddy, David Lewis, Hana Hassanin et al. · The Lancet HIV · 2019 · 134 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate

Antu Dey, Albert Cupo, Gabriel Ozorowski et al. · Biotechnology and Bioengineering · 2017 · 86 citations · Full text

Pharmacy, Biotechnology, Immunology +17

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

Michael C. Keefer, Jill Gilmour, Peter Hayes et al. · PLoS ONE · 2012 · 82 citations · Full text

Veterinary Medicine, Infectious Diseases, Immunization +16

A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers

Vadakkuppatu Devasenapathi Ramanathan, Makesh Kumar, Jayashri Mahalingam et al. · AIDS Research and Human Retroviruses · 2009 · 59 citations

Life Sciences, Immunology, Infectious Diseases +17

Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine

Sandhya Vasan, Sarah J. Schlesinger, Zhiwei Chen et al. · PLoS ONE · 2010 · 52 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17